RECOGNISING CLINICAL TRIALS AND THE PEOPLE BEHIND THE RESEARCH, NHMRC CEO signs off tenure with final co-presenter role at ACTA Trial of the Year Awards
With
Prof Christopher Reid, Board Chair
Australian Clinical Trials Alliance (ACTA)
Professor Steve Wesselingh, CEO
National Health and Medical Research Council (NHMRC)
Chandana Guha,
Australasian Kidney Trials Network
Dr Menglu Ouyang on behalf of Professor Craig Anderson
Australasian Stroke Trials Network with The George Institute for Global Health
Professor David Curtis
Australasian Leukaemia and Lymphoma Group
Delaine Smith
Chief Executive Officer
Australasian Leukaemia & Lymphoma Group
SEGMENT
Filmed in Sydney | August 2026
Australia’s clinical trials community came together to celebrate outstanding research and recognise the people and teams making a meaningful difference to healthcare at the 2026 ACTA Trial of the Year Awards.
Now in its 10th year, the awards continue to shine a light on investigator-led clinical trials and initiatives that are improving clinical practice, influencing healthcare policy and delivering better outcomes for patients across Australia and beyond.
This year’s awards showcased the breadth and strength of Australia’s clinical trials sector, with achievements recognised across six categories spanning clinical trials, statistics, health economics, implementation science, consumer involvement and clinical quality registries.
ACTA Chair, Professor Chris Reid, highlighted the contribution of the nominees and winners to the broader clinical trials community, noting the expertise, collaboration and commitment demonstrated through their work.
Since their establishment in 2016, the ACTA Trial of the Year Awards have provided an opportunity to recognise the impact of clinical research and celebrate the people behind the trials. The 2026 ceremony continued this tradition, highlighting the important role Australian researchers and collaborators play in advancing healthcare and improving the lives of patients.
Source: ACTA news story 19th August 2026 https://clinicaltrialsalliance.org.au/latest-news/celebrating-outstanding-achievements-in-clinical-trials/
-
HEALTH CARE BRIEF: Type 1 Diabetes (T1D)
Type 1 Diabetes – Incidence rates, management, lived experience & research
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
Study on digital tool for pharmacists in aged care
In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
